glutamic acid has been researched along with kavain in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (75.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beile, A; Gleitz, J; Peters, T | 1 |
Ameri, A; Beile, A; Friese, J; Gleitz, J; Peters, T | 1 |
Boonen, G; Ferger, B; Häberlein, H; Kuschinsky, K | 1 |
Ferger, B; Schmidt, N | 1 |
4 other study(ies) available for glutamic acid and kavain
Article | Year |
---|---|
(+/-)-kavain inhibits the veratridine- and KCl-induced increase in intracellular Ca2+ and glutamate-release of rat cerebrocortical synaptosomes.
Topics: Animals; Anti-Anxiety Agents; Calcium; Cerebral Cortex; Fura-2; Glutamic Acid; Ionophores; Male; Monensin; Potassium Chloride; Pyrones; Rats; Rats, Wistar; Synaptosomes; Veratridine | 1996 |
Anticonvulsive action of (+/-)-kavain estimated from its properties on stimulated synaptosomes and Na+ channel receptor sites.
Topics: 4-Aminopyridine; Animals; Anticonvulsants; Batrachotoxins; Calcium; Cerebral Cortex; Dose-Response Relationship, Drug; Glutamic Acid; Male; Pyrones; Rats; Rats, Wistar; Saxitoxin; Sodium; Sodium Channels; Synaptosomes | 1996 |
In vivo microdialysis study of (+/-)-kavain on veratridine-induced glutamate release.
Topics: Animals; Anticonvulsants; Brain; Drug Interactions; Glutamic Acid; Male; Microdialysis; Pyrones; Rats; Rats, Wistar; Tetrodotoxin; Veratridine | 1998 |
Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Anticonvulsants; Brain; Disease Models, Animal; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Glutamic Acid; Male; Mice; Mice, Inbred C57BL; Neostriatum; Nerve Degeneration; Neurons; Neuroprotective Agents; Parkinsonian Disorders; Pyrones; Substantia Nigra; Tyrosine 3-Monooxygenase | 2001 |